Venrock Healthcare Capital Partners

Venture capital

Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
15Deep-tech portfolio7 active
7Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Metsera
26Co-investorsShare a portfolio company
Matched to tracked deep-tech companies

Portfolio · 15 companies

CompanySectorStatusLatest raiseRaised
MetseraBiotechActiveNov 20, 2024$215.0M
Bright Peak TherapeuticsBiotechActiveJun 11, 2024$196.5M
Mirador TherapeuticsBiotechActiveApr 3, 2024$413.0M
AIRNABiotechActiveNov 24, 2021$1K
AdcendoBiotechActive——
Expedition TherapeuticsBiotechActive——
Timberlyne TherapeuticsBiotechActive——
Candid TherapeuticsBiotechAcquiredSep 13, 2024$206.2M
CytomX TherapeuticsBiotechPublicAug 17, 2023$143.0M
Artiva BiotherapeuticsBiotechPublicApr 5, 2021$163.4M
Unity BiotechnologyBiotechClosedMar 27, 2018$165.7M
enGene HoldingsBiotechPublic——
IlluminaMedtechPublic——
Singular GenomicsBiotechAcquired——
TubulisBiotechAcquired——
Among 276 venture investors with portfolios

Peer ranks

Portfolio size#28
Portfolio exits#26
Raises, 12 months#88
Co-investors#76
Share the most portfolio companies

Co-investors

Portfolio by sector

Sectors

  • Biotech14
  • Medtech1

Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.